🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟 OPENING CERENOMY: Welcome to all participants at #ESAM25 at the historic Palacio de los Condes de Valdeparaíso in Almagro! Excited to begin a weekend of learning, sharing and building connections all week long!

Looking back at the #CRS2024 in Bologna, please share in the comments below what you enjoyed most about last year's Annual Meeting & what you are looking forward to most for #CRS2025! 💫Register & learn more: ow.ly/gpak50V673J Tips for exploring Philadelphia: discoverPHL

New paper out in J Controlled Release ! This paper represents the core of my PhD in MJVicentPTLab: 🧫 Establising and characterizing advanced 3D models 💊 Optimizing them for nanomedicines evaluation 🧩 Characterizing and validating biomarkers for stimuli-responsive nanomedicines

Very proud, yet again, to have helped in the construction and editing of this cool new article from Paz Boix-Montesinos from the MJVicentPTLab at the CIPF.

Happy to announce the publication of a new paper by our PhD student Paz Boix-Montesinos 🎉🧫🧬 🔗 doi.org/10.1016/j.jcon… This work focuses on the identification of functional biomarkers for personalized nanomedicine using advanced in vitro models of breast cancer. Congratulations Paz 🥳

💫We're delighted to announce our second CRS 2025 Plenary Speaker, Professor Dame Molly Stevens, FREng, FRS! Reserve your spot at #CRS2025 now: ow.ly/72Re50VePOe Tips for exploring Philadelphia: discoverPHL

ADDR 50 days' free access: Human Pluripotent Stem Cell-based Cardiac Repair: Lessons Learned and Challenges Ahead. By Michael A. Laflamme & coworkers McEwen Stem Cell Institute #StemCell #CardiacRepair kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Size-dependent penetration depth of colloidal nanoparticles into cell spheroids. By Wolfgang J. Parak & coworkers, Univ. of Hamburg Controlled Release Society - GerChAt Chapter #GoldNanoparticle #size #spheroid #penetration kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ow.ly/qIKw50VTkKY

ADDR Open Access: Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities. By Morten Otto Alexander Sommer & coworkers DTU #OralDelivery #absorption #microbiome kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Advances in Photoactivated Carbon-based Nanostructured Materials for Targeted Cancer Therapy. By Hossein Heidari & coworkers UCL UKICRS #graphene #nanosheet #phototherapy #photoacoustic kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Enhancing Organoid Technology with Carbon-Based Nanomaterial Biosensors: Advancements, Challenges, and Future Directions. By Su Ryon Shin & coworkers Harvard Medical School #organoid #biosensor kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Advances in Enhancing Photoprotection of Sunscreens Using Hydrocarbon Film Formers and Carbon Nanomaterials. By Paul S. Weiss & coworkers UCLA Chem & Biochem #CarbonNanomaterial #sunscreen kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Nanomedicine for Targeting Brain Neurodegeneration: Critical Barriers and Circadian Rhythm Considerations. By María José Alonso & coworkers USC CRS Spanish Portuguese Local Chapter #BrainDelivery #BloodBrainBarrier #chronotherapy kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Maximizing Therapeutic Potential and Safety: Exploring Multi/Dual-Payload Antibody Conjugates as Cancer Theranostics. By Humphrey Fonge & coworkers Université Laval #AntibodyDrugConjugate #theranostic #safety kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Enabling Technologies for in situ Biomanufacturing using Probiotic Yeast. By Nathan Crook & coworkers NC State University #probiotic #biomanufacturing kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR 50 days' free access: Circadian attributes of neurological and psychiatric disorders as basis for their medication chronotherapy. By Sepideh Khoshnevis Texas BME #chronotherapy #CircadianRhythm kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Congratulations to Maria J. Vicent Maria J. Vicent, Editor-in-Chief of ADDR, on receiving the prestigious Jaume I Award in New Technologies! A truly well-deserved recognition. levante-emv.com/comunitat-vale…

ADDR 50 days' free access: DNA-based Nanostructures for Tumor Microenvironment-Responsive Drug Delivery. By Dayong Yang & coworkers Tianjin University #DNAnanostructure #TumorMicroenvironment kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

ADDR Open Access: Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting. By Maria Laura Bolognesi & coworkers Università di Bologna #BloodBrainBarrier #CircadianClock kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…